Boston Scientific Corp. on Tuesday raised its full-year adjusted-earnings guidance.
The Marlborough, Mass.-based medical-devices maker said it now expects adjusted earnings of $1.58 a share to $1.62 a share in 2021. The company had previously forecast adjusted earnings of $1.53 a share to $1.60 a share. Boston Scientific forecast sales reported growth of 21% to 22% in 2021.
The company also issued guidance for the third quarter, forecasting adjusted earnings of 39 cents a share to 41 cents a share on sales growth of 12% to 14% year over year. Analysts had been expecting third-quarter adjusted earnings of 40 cents a share.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.